This review by G. Morin, I. Galasso and G. Canaud @inem-necker.bsky.social @upcite.bsky.social presents an overview of the genetic basis of #VascularMalformations (VMs), discussing the ongoing evolution of #PrecisionMedicine for these conditions.

➡️ doi.org/10.1038/s443...

Click birthmark.org/wp-content/u... to read this important publication related to Vascular Birthmarks, Anomalies, and Related Syndromes (VBARS).

#IndustryExperts #VascularBirthmarks #VascularLesions #VascularMalformations

Somatic #PIK3R1 mutations in the iSH2 domain are accessible to PI3Kα inhibition.

By G. Morin, A. P. Garneau, G. Canaud & colleagues @inem-necker.bsky.social

#VascularMalformations #OvergrowthSyndrome

➡️ doi.org/10.1038/s443...

Embryological cellular origins & #hypoxia -mediated mechanisms in #PIK3CA -driven refractory #VascularMalformations

By S. Torii, K. Maruyama & colleagues at Mie University, Japan

🗞️ doi.org/10.1038/s443...

Had the absolute pleasure of hosting the Leducq ReVAMP biannual meeting @riken-bdr.bsky.social in Kobe this spring! #endothelial #mechanobiology #vascularmalformations See you all again in Fall @ondinecleaver.bsky.social @mvikkula.bsky.social

1/6 🚨 91% of patients with low-flow vascular malformations reported improved symptoms and quality of life after sclerotherapy!

Discover the newly published study in @cvirendo on the standardized assessment of sclerotherapy outcomes 👇 🩺📊

#VascularMalformations #Sclerotherapy

1/6 🚨 91% of patients with low-flow vascular malformations reported improved symptoms and quality of life after sclerotherapy!

Discover the newly published study in @cvirendo on the standardized assessment of sclerotherapy outcomes 👇 🩺📊

#VascularMalformations #Sclerotherapy